HIMS vs. CLS
HIMS (Hims & Hers Health, Inc.) and CLS (Celestica Inc.) are both stocks. HIMS operates in Household & Personal Products (Consumer Defensive), while CLS operates in Electronic Components (Technology). Over the past 5 years, HIMS returned 15.10%/yr vs 114.81%/yr for CLS. At a 0.28 correlation, their price movements are largely independent.
Performance
HIMS vs. CLS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HIMS achieves a -16.32% return, which is significantly lower than CLS's 30.75% return.
HIMS
- 1D
- 3.74%
- 1M
- -3.89%
- YTD
- -16.32%
- 6M
- -30.55%
- 1Y
- -51.77%
- 3Y*
- 44.53%
- 5Y*
- 15.10%
- 10Y*
- —
CLS
- 1D
- 3.98%
- 1M
- 2.92%
- YTD
- 30.75%
- 6M
- 13.42%
- 1Y
- 220.14%
- 3Y*
- 209.55%
- 5Y*
- 114.81%
- 10Y*
- 43.16%
HIMS vs. CLS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
HIMS Hims & Hers Health, Inc. | -16.32% | 34.28% | 171.69% | 38.85% | -2.14% | -55.14% | 47.47% | 1.23% |
CLS Celestica Inc. | 30.75% | 220.27% | 215.23% | 159.80% | 1.26% | 37.92% | -2.42% | 12.36% |
Correlation
The correlation between HIMS and CLS is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.34 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | 0.28 |
Fundamentals
HIMS:
$6.20B
CLS:
$44.72B
HIMS:
-$0.05
CLS:
$8.28
HIMS:
2.81
CLS:
3.24
HIMS:
13.91
CLS:
21.31
HIMS:
$2.37B
CLS:
$13.81B
HIMS:
$1.70B
CLS:
$1.60B
HIMS:
$16.04M
CLS:
$1.32B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HIMS vs. CLS — Risk / Return Rank
HIMS
CLS
HIMS vs. CLS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and Celestica Inc. (CLS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HIMS | CLS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.60 | ||
| Sortino ratioReturn per unit of downside risk | -3.36 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 1.39 | -0.44 |
| Calmar ratioReturn relative to maximum drawdown | -0.67 | 7.58 | -8.25 |
| Martin ratioReturn relative to average drawdown | -1.09 | 18.88 | -19.97 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HIMS | CLS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.54 | 3.06 | -3.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.18 | 2.01 | -1.82 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.87 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | 0.27 | -0.06 |
Drawdowns
HIMS vs. CLS - Drawdown Comparison
The maximum HIMS drawdown since its inception was -87.29%, smaller than the maximum CLS drawdown of -96.93%. Use the drawdown chart below to compare losses from any high point for HIMS and CLS.
Loading charts...
Drawdown Indicators
| HIMS | CLS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.29% | -96.93% | +9.64% |
Max Drawdown (1Y)Largest decline over 1 year | -78.06% | -29.24% | -48.82% |
Max Drawdown (3Y)Largest decline over 3 years | -78.88% | -53.96% | -24.92% |
Max Drawdown (5Y)Largest decline over 5 years | -78.88% | -53.96% | -24.92% |
Max Drawdown (10Y)Largest decline over 10 years | — | -80.60% | — |
Current DrawdownCurrent decline from peak | -60.47% | -18.18% | -42.29% |
Average DrawdownAverage peak-to-trough decline | -43.22% | -73.36% | +30.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.51% | 11.72% | +35.79% |
Volatility
HIMS vs. CLS - Volatility Comparison
Hims & Hers Health, Inc. (HIMS) and Celestica Inc. (CLS) have volatilities of 26.28% and 26.60%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HIMS | CLS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.28% | 26.60% | -0.32% |
Volatility (6M)Calculated over the trailing 6-month period | 66.46% | 55.08% | +11.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 96.13% | 72.52% | +23.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.39% | 57.62% | +25.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.19% | 49.93% | +27.26% |
Dividends
HIMS vs. CLS - Dividend Comparison
Neither HIMS nor CLS has paid dividends to shareholders.
Financials
HIMS vs. CLS - Financials Comparison
This section allows you to compare key financial metrics between Hims & Hers Health, Inc. and Celestica Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HIMS vs. CLS - Profitability Comparison
HIMS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.
CLS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a gross profit of 437.20M and revenue of 4.05B. Therefore, the gross margin over that period was 10.8%.
HIMS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.
CLS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported an operating income of 272.10M and revenue of 4.05B, resulting in an operating margin of 6.7%.
HIMS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.
CLS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a net income of 212.30M and revenue of 4.05B, resulting in a net margin of 5.3%.
Frequently Asked Questions
HIMS and CLS have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLS has higher volatility (26.60%) compared to HIMS (26.28%). In terms of maximum drawdown, HIMS dropped -87.29% vs CLS's -96.93%.
CLS currently has the higher Sharpe Ratio (3.06 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HIMS and CLS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer